(Q78854002)

English

Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache

scientific article published on 01 December 1960

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

title

Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

GRAHAM JR

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

language of work or name

English

0 references

publication date

1 December 1960

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

published in

The New England Journal of Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

volume

263

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

page(s)

1273-1277

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

Identifiers

DOI

10.1056/NEJM196012222632502

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

retrieved

17 December 2019

PubMed publication ID

13707731

1 reference

stated in

Europe PubMed Central

PubMed publication ID

13707731

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13707731%20AND%20SRC:MED&resulttype=core&format=json

(Q78854002)

Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)